Kari Hemminki
181 – 190 of 526
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer
(
- Contribution to journal › Article
-
Mark
Risk of Next Melanoma in Patients With Familial and Sporadic Melanoma by Number of Previous Melanomas.
(
- Contribution to journal › Article
-
Mark
Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumors.
(
- Contribution to journal › Article
-
Mark
Telomere length in circulating lymphocytes: Association with chromosomal aberrations.
(
- Contribution to journal › Letter
-
Mark
Special section editorial: Cancer incidence in five continents including Africa.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Heritability estimates on Hodgkin's lymphoma: a genomic- versus population-based approach.
(
- Contribution to journal › Article
-
Mark
A simple-to-use method incorporating genomic markers into prostate cancer risk prediction tools facilitated future validation.
(
- Contribution to journal › Article
-
Mark
TERT promoter mutations in clear cell renal cell carcinoma
(
- Contribution to journal › Article
-
Mark
Cancer Risk in Relatives of Testicular Cancer Patients by Histology Type and Age at Diagnosis: A Joint Study from Five Nordic Countries.
(
- Contribution to journal › Article
-
Mark
Risk of Cancer of Unknown Primary after Hospitalization for Autoimmune Diseases.
(
- Contribution to journal › Article